Annual Clinical Updates in Hematological Malignancies: A Continuing Medical Education Series: Polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management

Medicine & Life Sciences

• Essential Thrombocythemia 100%
• Continuing Medical Education 98%
• Polycythemia Vera 96%
• Risk Management 81%
• Hematologic Neoplasms 75%
• Thrombocytosis 17%
• Primary Myelofibrosis 16%
• Hydroxyurea 16%
• Thrombosis 15%
• Leukocytosis 14%
• Erythropoietin 14%
• Busulfan 8%
• Polycythemia 8%
• Phlebotomy 8%
• Mutation 7%
• Splenomegaly 7%
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7%
• Pruritus 6%
• Platelet Count 6%
• Aspirin 6%
• Interferons 6%
• Serum 6%
• Anemia 5%
• Leukemia 5%
• Disease Progression 5%
• Differential Diagnosis 5%
• Bone Marrow 4%
• Hemorrhage 4%
• Therapeutics 3%
• Neoplasms 2%